Tag: Notice
-
ClinicalTrials.gov Pre-Notice & Notice of Noncompliance
The Food and Drug Administration (FDA) is taking action to ensure certain information in ClinicalTrials.gov is available to the public. On April 28, 2021, the FDA issued its first notice of non-compliance for failing to submit required results information. A Notice of Noncompliance indicates that the FDA has determined the Responsible Party (Principal Investigator) was…
-
NIH Expands Notice of Interest in Diversity
On November 22, 2019, the NIH rescinded its 2018 Notice of Interest in Diversity (NOT-OD-18-210) and replaced it with an expanded Notice of Interest in Diversity (NOT-OD-20-031). In this expanded notice, the NIH issued the following revised diversity statement: “In spite of tremendous advancements in scientific research, information, educational and research opportunities are not equally…
-
Application Completeness and Compliance Stressed in NIH Notice
NOTICE from NIH: NIH Applications Must Be Complete and Compliant with NIH Policy and Application Instructions at the Time of Submission NIH has issued a notice (NOT-OD-17-105) reminding all applicants that NIH will consistently apply standards for applications completeness and for compliance with all submission requirements and NIH policies. The notice did not include any…